Even if no difference appears to exist between obese and controls (98), serum sclerostin was found to be negatively associated with insulin sensitivity in obese but not lean subjects, suggesting a potential role for the Wnt/β-catenin pathway in regulating insulin sensitivity in obesity (99). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.